← Eichor
Condition: Clostridium Difficile Colitis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Clostridium Difficile Colitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Stool Transplants to Treat Refractory Clostridium Difficile Colitis
Phase 2 · 1 location(s) · Duke University · NCT02127398
Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population
Phase 1 · 2 location(s) · University of Alberta · NCT07401680
Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
Phase 2 · 2 location(s) · University of Virginia · NCT04305769
FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach
Phase 1/Phase 2 · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06071312
Safety and Efficacy of Fecal Microbiota Transplantation
NA · 1 location(s) · Chinese University of Hong Kong · NCT04014413
Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative Colitis
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06228352
Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics
Phase N/A · 1 location(s) · Chen QiYi · NCT07261826
Vancomycin Taper to Prevent Recurrent Clostridioides Difficile
Phase 3 · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT07328971
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.